Succinyl phosphonate (trisodium salt)
CAT:
804-HY-12688A-01
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Succinyl phosphonate (trisodium salt)
UNSPSC Description:
Succinyl phosphonate trisodium salt is an α-ketoglutarate dehydrogenase (KGDHC) inhibitor, effective inhibits (KGDHC) in muscle, bacterial, brain, and cultured human fibroblasts[1][4]. Succinyl phosphonate trisodium salt is an 2-oxoglutarate dehydrogenase (OGDH) inhibitor, impairs viability of cancer cells in a cell-specific metabolism-dependent manner[2]. Succinyl phosphonate trisodium salt inhibits the glutamate-induced ROS production in glutamate-stimulated hippocampal neurons in situ[3].Target Antigen:
Endogenous Metabolite; Reactive Oxygen SpeciesType:
Reference compoundRelated Pathways:
Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κBField of Research:
Cancer; Metabolic Disease; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/succinyl-phosphonate-trisodium-salt.htmlPurity:
98.0Solubility:
H2O : 50 mg/mL (ultrasonic)Smiles:
O=C(O[Na])CCC(P(O[Na])(O[Na])=O)=OMolecular Weight:
248.01References & Citations:
[1]Biryukov AI, et al. Succinyl phosphonate inhibits alpha-ketoglutarate oxidative decarboxylation, catalyzed by alpha-ketoglutarate dehydrogenase complexes from E. coli and pigeon breast muscle. FEBS Lett. 1996 Mar 11;382(1-2):167-70.|[2]Bunik VI, et al. Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner. Oncotarget. 2016 May 3;7(18):26400-21.|[3]Zündorf G, et al. alpha-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ. Neuroscience. 2009 Jan 23;158(2):610-6.|[4]Bunik VI, et al. Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutarate dehydrogenase complex isolated from brain and in cultured cells. Biochemistry. 2005 Aug 9;44(31):10552-61.|[5]Artiukhov AV, et al. Increasing Inhibition of the Rat Brain 2-Oxoglutarate Dehydrogenase Decreases Glutathione Redox State, Elevating Anxiety and Perturbing Stress Adaptation. Pharmaceuticals (Basel). 2022 Jan 31;15(2):182.bioRxiv. 2024 Jan 15.|Research Square Preprint. 2022.|Research Square Print. 2022 May.|ACS Chem Biol. 2020 Aug 21;15(8):2041-2047.|Cancer Res. 2019 Jul 1;79(13):3281-3293. |Cell Death Dis. 2021 Oct 25;12(11):999.|Exp Cell Res. 2019 Sep 15;382(2):111483. |Free Radic Biol Med. 2016 Apr 9;96:22-33. |Plant Signal Behav. 2019;14(7):1604015.|Planta. 2018 Oct;248(4):963-979.|Redox Biol. 2023 Jun.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Clinical Information:
No Development ReportedCAS Number:
864167-45-3